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Background: Malignant ventricular tachyarrhythmias (VT) such as ventricular tachycardia and fibrillation in hypertrophic cardiomyopathy 
(HCM) can be related to the extent of myocardial fibrosis with or without cardiac dysfunction. Although late gadolinium enhancement (LGE) on 
cardiovascular magnetic resonance (CMR) has been used to detect myocardial fibrosis, few data exist regarding CMR-determined myocardial fibrosis 
and VT in HCM with sarcomere protein gene mutations.
Methods: CMR, echocardiography and 24-hour ambulatory electrocardiographic monitoring were performed in 35 HCM patients (23 women, mean 
age 54.9 years) with sarcomere protein gene mutations (TNNI3=22, MYBPC3=12, MYH7=1). CMR images were acquired on a 1.5T scanner and 
contrast-enhanced images were performed with a segmented inversion-recovery sequence.
Results: On echocardiograms, maximal wall thickness was 16.3±4.7 mm and ejection fraction was 63.2±14.3 %. LGE was found in 30 (85.7%) 
of the examined patients and the mean extent of LGE was 10.1±12.4%. Interestingly, the extent of LGE was greater in the group of VT (21.8 + 
14.5 %, n=8) than that in the group of non VT (6.6 + 9.4%, n=27, p<0.01), suggesting the relationship between the extent myocardial fibrosis and 
occurrence of VT.
Conclusions: These results demonstrate that CMR-determined myocardial fibrosis could be indicative of VT. We suggest the intensive anti-
arrhythmic treatment for these HCM patients even though cardiac function is not impaired.
